DDIT3 and myeloid sarcoma: Upregulated UPR markers, such as GRP78 and CHOP in MS lesions, support this idea that failure of the UPR‐protective mechanisms triggers neurotoxicity through exacerbating inflammatory responses and apoptotic pathways (Antony et al., 2011).